Benchmarking confidence estimation and rescoring for cyclic peptide–protein complex predictions
Year: 2026
Type: preprint
Abstract: Cyclic peptides are a rapidly expanding class of therapeutics, but the reliability of deep-learning structure prediction for cyclic peptide–protein complexes has not been systematically evaluated. We assembled a curated benchmark of 111 non-redundant complexes spanning five cyclization chemistries and assessed two co-folding models, Boltz and Protenix, each generating 100 poses per target (22,200 total). Stratifying all poses by complex attributes, we found that disulfide-cyclized peptides and small protein targets (200 or fewer target residues) were predicted significantly worse by both tools, with target size the largest and most consistent effect; overall accuracy nevertheless remained high (median top-pose DockQ of about 0.89, 96–98% of targets Acceptable or better), indicating that pose generation is rarely the bottleneck. Conversely, native model ranking scores correlated only moderately with pose quality (Spearman rank correlations of 0.53–0.66): approximately 12% of poses showed high model ranking score/confidence despite poor pose DockQ quality, and the highest-quality pose was not ranked first for nearly every target. We therefore augmented the native score with externally computed interface descriptors normalized by chain length, principally the per-residue density of inter-chain hydrogen bonds, in a gradient-boosted rescoring model evaluated under target-grouped cross-validation that prevents leakage, improving out-of-fold ROC-AUC for both tools, significantly so for Protenix. Together, these findings identify pose ranking, rather than pose generation, as the major limitation of current cyclic peptide–protein complex prediction and demon-strate that complementary structural features can improve confidence-based pose selection.
Authors: Zhe Li, Ye Yuan, Kaiqiang Hu, Pengwei Pan, Fang He
Institution: Pharmaron (China)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funder: Pharmaron
OpenAlex ID: W7203971069